Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued on Monday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Stock Down 8.3 %

Shares of MLSS opened at $0.99 on Monday. The stock has a market cap of $77.11 million, a P/E ratio of -14.14 and a beta of 1.41. The business’s 50 day moving average price is $1.11 and its 200-day moving average price is $0.96. Milestone Scientific has a 52 week low of $0.54 and a 52 week high of $1.39.

Hedge Funds Weigh In On Milestone Scientific

Several institutional investors and hedge funds have recently modified their holdings of MLSS. World Investment Advisors LLC bought a new position in Milestone Scientific in the 3rd quarter worth about $91,000. Renaissance Technologies LLC lifted its stake in shares of Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after buying an additional 53,198 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific during the third quarter valued at approximately $48,000. Geode Capital Management LLC increased its position in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares in the last quarter. Finally, Carnegie Investment Counsel raised its holdings in Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after acquiring an additional 27,412 shares during the last quarter. 5.79% of the stock is currently owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.